Arcam, listed on NASDAQ OMX, has received an order for an Arcam Q10 system from an implant manufacturer in Europe. ”This is an order from a new customer in the implant industry. Our new EBM system range, the Q-series, is well received and the Arcam Q10, designed for implant manufacturing, helps us reach new customers”, says Magnus René, CEO of Arcam. The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published on February 11, 2014. For further information please contact: Magnus René, CEO Arcam AB Tel: 46 31 710 32 00, alt. cell: 46 702 79 89 99, or e-mail: magnus.rene@arcam.com Arcam provides a cost-efficient Additive Manufacturing solution for production of metal components. The technology offers freedom in design combined with excellent material properties and high productivity. Arcam’s market is global with customers mainly in the orthopedic and aerospace industries. The company was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office and production facilities are located in Mölndal, Sweden. Support offices are located in the US, UK, Italy and China. ________________________________________________________________________________ _ _______ Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00 • www.arcam.com